January 05, 2022

The Future of Due Diligence in Healthcare M&A

COVID-19 placed healthcare squarely in the center of everyone’s mind. From fledgling startups to large corporates, the healthcare industry is modernizing itself at lightning speed.

To make that happen, deal activity within healthcare has exploded at dizzying rates. R&D breakthroughs, point-of-care disruption, and strategic plays into digital health make the healthcare sector one rich with opportunity and risk. To manage that risk, staying on top of due diligence best practices is critical. In this whitepaper, we explore:

  • Current healthcare M&A due diligence benchmarks 
  • Trends reshaping the face of healthcare due diligence
  • An updated healthcare due diligence checkup list

Download the whitepaper and learn more. 

Ready to Get Started?

You may also like:

Deal Drivers: APAC 2022 Outlook

Read this Deal Drivers outlook report and learn about the top five predictions on the factors that will influence APAC dealmaking in 2022 along with the latest heat chart, showing the sectors and regions where activity is likely to dominate based on ‘companies for sale’ tracked by Mergermarket.

Deal Drivers: Americas 2022 Outlook

The stellar momentum of M&A in the Americas looks set to continue from 2021. But which sectors and locations will see most activity? Explore the key factors and our five predictions for dealmakers in 2022.

Columbia City Landscape
TTR LATAM – November 2021 Report

The report also includes a breakdown of M&A activity by sector, alongside information and data related to Private Equity and Venture Capital investments. League tables in the final pages of the report rank the top legal and financial advisors by the volume of deals announced in 2021.

M & A Professionals discussing a Data Room